FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2504424811> ?p ?o ?g. }

• W2504424811 abstract "Introduction: Ovarian cancer generates unique tumor microenvironment (TME) that promotes and enhances tumor progression and metastasis. Current therapy option for modulating ovarian TME is antiangiogenic therapy but its clinical benefit is limited; thus, alternative drug targets are needed for therapeutic durability. Apelin and its cognate receptor APJ is known to have roles in glucose metabolism, cardiovascular functions, and angiogenesis. We found that apelin/APJ are highly overexpressed in human ovarian tumors, but their functional role is unclear. We also found a significant upregulation of apelin/APJ in tumors that progressed after antiangiogenic therapy in preclinical ovarian cancer models. Our objective is to determine the functional roles and mechanisms of apelin/APJ pathway on promoting ovarian tumor angiogenesis and progression. Methods: We examined autocrine and paracrine functions of apelin/APJ signaling on cell proliferation, migration, and tube formation using human ovarian cancer cells (SKOV3Apln and SKOV3Apj) and endothelial cells (HUVECApj). Phosphoproteome array was performed to evaluate the apelin/APJ downstream signaling. We characterized the effect of apelin or APJ overexpression on tumor development and response to VEGFR inhibitor in vivo. To confirm the clinical relevance of apelin/APJ in ovarian TME, we measured soluble apelin levels in patients’ ascites and APJ expressions in human ovarian tumors using an immunohistochemistry. Results: Apelin (10-100 ng/ml) induced mitogenic and chemoattractant effects on both cancer and endothelial cells. These effects were more prominent under hypoxic condition, reflecting the significance of apelin/APJ axis in TME. The aplein-mediated proliferative and migratory effects were inhibited by a pharmacological APJ inhibitor (ML-221) in a dose-dependent manner. High APJ expression resulted in enhanced pro-angiogenic activity in HUVEC. Overexpression of apelin/APJ also led to reduced response to antiangiogenic treatment in both HUVEC and cancer cells. Apelin signaling induces phosphorylation of AKT, STAT, CREB, PRAS 40, and AMPKα2 in SKOV3 cells. Our xenograft study indicates APJ-overexpressing tumors showed reduced response to sorafenib treatment compared to those control tumors. We found that APJ is mainly expressed in tumors and some extent in stromal component of human ovarian tumors. The median soluble apelin levels in ascites were 187 pg/ml (6.3 - 4,000 pg/ml). Conclusions: Our results suggest that apelin/APJ may play an important role in promoting angiogenesis and progression in ovarian cancer and serve as an attractive pathway targeting ovarian TME. Citation Format: Bharat Kumar Devapatla, Pharavee Jaiprasart, Samrita Dogra, Jihee Ha, Sukyung Woo. Apelin/Apj pathway for targeting ovarian tumor microenvironment. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1272." @default.
• W2504424811 created "2016-08-23" @default.
• W2504424811 creator A5003665474 @default.
• W2504424811 creator A5003787066 @default.
• W2504424811 creator A5038076814 @default.
• W2504424811 creator A5060845999 @default.
• W2504424811 creator A5064885038 @default.
• W2504424811 date "2016-07-15" @default.
• W2504424811 modified "2023-09-27" @default.
• W2504424811 title "Abstract 1272: Apelin/Apj pathway for targeting ovarian tumor microenvironment" @default.
• W2504424811 doi "https://doi.org/10.1158/1538-7445.am2016-1272" @default.
• W2504424811 hasPublicationYear "2016" @default.
• W2504424811 type Work @default.
• W2504424811 sameAs 2504424811 @default.
• W2504424811 citedByCount "1" @default.
• W2504424811 countsByYear W25044248112021 @default.
• W2504424811 crossrefType "proceedings-article" @default.
• W2504424811 hasAuthorship W2504424811A5003665474 @default.
• W2504424811 hasAuthorship W2504424811A5003787066 @default.
• W2504424811 hasAuthorship W2504424811A5038076814 @default.
• W2504424811 hasAuthorship W2504424811A5060845999 @default.
• W2504424811 hasAuthorship W2504424811A5064885038 @default.
• W2504424811 hasConcept C121608353 @default.
• W2504424811 hasConcept C126322002 @default.
• W2504424811 hasConcept C128240485 @default.
• W2504424811 hasConcept C134018914 @default.
• W2504424811 hasConcept C170493617 @default.
• W2504424811 hasConcept C2776107976 @default.
• W2504424811 hasConcept C2779546753 @default.
• W2504424811 hasConcept C2780084626 @default.
• W2504424811 hasConcept C2780394083 @default.
• W2504424811 hasConcept C2780427987 @default.
• W2504424811 hasConcept C502942594 @default.
• W2504424811 hasConcept C71924100 @default.
• W2504424811 hasConcept C7876069 @default.
• W2504424811 hasConcept C86803240 @default.
• W2504424811 hasConceptScore W2504424811C121608353 @default.
• W2504424811 hasConceptScore W2504424811C126322002 @default.
• W2504424811 hasConceptScore W2504424811C128240485 @default.
• W2504424811 hasConceptScore W2504424811C134018914 @default.
• W2504424811 hasConceptScore W2504424811C170493617 @default.
• W2504424811 hasConceptScore W2504424811C2776107976 @default.
• W2504424811 hasConceptScore W2504424811C2779546753 @default.
• W2504424811 hasConceptScore W2504424811C2780084626 @default.
• W2504424811 hasConceptScore W2504424811C2780394083 @default.
• W2504424811 hasConceptScore W2504424811C2780427987 @default.
• W2504424811 hasConceptScore W2504424811C502942594 @default.
• W2504424811 hasConceptScore W2504424811C71924100 @default.
• W2504424811 hasConceptScore W2504424811C7876069 @default.
• W2504424811 hasConceptScore W2504424811C86803240 @default.
• W2504424811 hasLocation W25044248111 @default.
• W2504424811 hasOpenAccess W2504424811 @default.
• W2504424811 hasPrimaryLocation W25044248111 @default.
• W2504424811 hasRelatedWork W1968553594 @default.
• W2504424811 hasRelatedWork W1993571844 @default.
• W2504424811 hasRelatedWork W2022063299 @default.
• W2504424811 hasRelatedWork W2025669366 @default.
• W2504424811 hasRelatedWork W2030507184 @default.
• W2504424811 hasRelatedWork W2084929559 @default.
• W2504424811 hasRelatedWork W2089620693 @default.
• W2504424811 hasRelatedWork W2091421163 @default.
• W2504424811 hasRelatedWork W2091572283 @default.
• W2504424811 hasRelatedWork W2094609870 @default.
• W2504424811 hasRelatedWork W2320990135 @default.
• W2504424811 hasRelatedWork W2428924377 @default.
• W2504424811 hasRelatedWork W2498781425 @default.
• W2504424811 hasRelatedWork W2499416018 @default.
• W2504424811 hasRelatedWork W2560265837 @default.
• W2504424811 hasRelatedWork W2567303579 @default.
• W2504424811 hasRelatedWork W2896285889 @default.
• W2504424811 hasRelatedWork W2905559703 @default.
• W2504424811 hasRelatedWork W3155144684 @default.
• W2504424811 hasRelatedWork W3187842754 @default.
• W2504424811 isParatext "false" @default.
• W2504424811 isRetracted "false" @default.
• W2504424811 magId "2504424811" @default.
• W2504424811 workType "article" @default.